Equalizing
precision medicine...

...because we believe in better health outcomes for all.

As a life sciences company, we’re building diverse datasets to advance research and improve diagnostic and treatment outcomes for Africans and the global population

Find out more

How we do it

Our proprietary GENIISYS™ contains highly curated genomics, clinical and phenotypic data from which we generate insights that lead to new treatments and diagnostics.

What we do

GENIISYS™ underpins our three distinct, but synergistic business lines, which converge to deliver on the promise and power of equalizing precision medicine for all.

These business lines – drug discovery, molecular diagnostics, and clinical trial programs – are specifically inclusive of African populations, which demonstrates 54gene’s Commitment to Africa and Partnering with other mission-driven organizations seeking to enable global access of precision medicine for all.

Drug Discovery

Our drug discovery platform business leverages data-driven insights from our genomic studies given the great discovery potential within Africa for rare genetic variants.

Find out more

Molecular Diagnostics

Our molecular diagnostics platform supplies lower-cost testing solutions to aid clinicians and their patients with the ability to locally diagnose and match the right treatment for a range of conditions.

Find out more

Clinical Trial Programs

Our clinical trial platform provides study management solutions for collaborators and partners seeking to conduct genomic-guided trials within Africa.

Find out more

Stay
in the know

To keep up to date with events, services and initiatives, subscribe to our newsletter today.